Search
for
Sort by
Research 91–120 of 132
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Research gaps in medical treatment of transgender/nonbinary people
- Hormone Therapy in the Era of the COVID-19 Pandemic: A Review
- Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences
- Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)
- Baricitinib for the Treatment of Alopecia Areata
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- Management of transgender patients in critical care
- Southern African HIV Clinicians Society gender-affirming healthcare guideline for South Africa
- Antiandrogenic therapy with ciproterone acetate in female patients who suffer from both androgenetic alopecia and acne vulgaris
- The Combination of Natural Compounds Escin–Bromelain–Ginkgo Biloba–Sage Miltiorrhiza (EBGS) Reduces Platelet Adhesion to TNFα-Activated Vascular Endothelium through FAK Signaling
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Hormonal Therapies in Cosmetic Dermatology: Mechanisms, Clinical Applications, and Future Perspectives
- Medical Dermatology
- JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study
- Forensic approach in cases of anabolic-androgenic steroid abuse and cardiovascular mortality: insights from autopsy, histopathology, immunohistochemistry and toxicology
- Multidisciplinary screening and diagnosis of obesity related diseases: an Arabic Association for the Study of Diabetes and metabolism position statement (AASD)
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Exploring Hormone Therapy Effects on Reproduction and Health in Transgender Individuals
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- What you need to know about gender‐affirming healthcare
- Global Landscapes of Human Phenotypic Variation in Inherited Traits
- CLINICAL AND LABORATORY STUDIES ON EMACIATION AND ILL-THRIFTINESS IN CATTLE AT ASWAN GOVERNORATE
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US